The 5th edition of the World Health Organization classification of haematolymphoid tumours: lymphoid neoplasms R Alaggio, C Amador, I Anagnostopoulos, AD Attygalle, IBO Araujo, ... Leukemia 36 (7), 1720-1748, 2022 | 1668 | 2022 |
The impact of the methotrexate administration schedule and dose in the treatment of children and adolescents with B-cell neoplasms: a report of the BFM Group Study NHL-BFM95 W Woessmann, K Seidemann, G Mann, M Zimmermann, B Burkhardt, ... Blood 105 (3), 948-958, 2005 | 447 | 2005 |
The impact of age and gender on biology, clinical features and treatment outcome of non‐Hodgkin lymphoma in childhood and adolescence B Burkhardt, M Zimmermann, I Oschlies, F Niggli, G Mann, R Parwaresch, ... British journal of haematology 131 (1), 39-49, 2005 | 397 | 2005 |
Translocations activating IRF4 identify a subtype of germinal center-derived B-cell lymphoma affecting predominantly children and young adults I Salaverria, C Philipp, I Oschlies, CW Kohler, M Kreuz, M Szczepanowski, ... Blood, The Journal of the American Society of Hematology 118 (1), 139-147, 2011 | 288 | 2011 |
Prognostic factors in childhood anaplastic large cell lymphoma: results of a large European intergroup study MC Le Deley, A Reiter, D Williams, G Delsol, I Oschlies, K McCarthy, ... Blood, The Journal of the American Society of Hematology 111 (3), 1560-1566, 2008 | 230 | 2008 |
Diffuse large B-cell lymphoma in pediatric patients belongs predominantly to the germinal-center type B-cell lymphomas: a clinicopathologic analysis of cases included in the … I Oschlies, W Klapper, M Zimmermann, M Krams, HH Wacker, B Burkhardt, ... Blood 107 (10), 4047-4052, 2006 | 214 | 2006 |
A recurrent 11q aberration pattern characterizes a subset of MYC-negative high-grade B-cell lymphomas resembling Burkitt lymphoma I Salaverria, I Martin-Guerrero, R Wagener, M Kreuz, CW Kohler, J Richter, ... Blood, The Journal of the American Society of Hematology 123 (8), 1187-1198, 2014 | 211 | 2014 |
Ki-67 as a prognostic marker in mantle cell lymphoma—consensus guidelines of the pathology panel of the European MCL Network W Klapper, E Hoster, O Determann, I Oschlies, J van der Laak, F Berger, ... Journal of hematopathology 2, 103-111, 2009 | 194 | 2009 |
Prognostic impact of morphologic and phenotypic features of childhood ALK-positive anaplastic large-cell lymphoma: results of the ALCL99 study L Lamant, K McCarthy, E d'Amore, W Klapper, A Nakagawa, M Fraga, ... Journal of Clinical Oncology 29 (35), 4669-4676, 2011 | 172 | 2011 |
Prognostic significance of circulating tumor cells in bone marrow or peripheral blood as detected by qualitative and quantitative PCR in pediatric NPM-ALK–positive … C Damm-Welk, K Busch, B Burkhardt, J Schieferstein, S Viehmann, ... Blood, The Journal of the American Society of Hematology 110 (2), 670-677, 2007 | 169 | 2007 |
Pediatric follicular lymphoma–a clinico-pathological study of a population-based series of patients treated within the Non-Hodgkin’s Lymphoma-Berlin-Frankfurt-Münster (NHL-BFM … I Oschlies, I Salaverria, F Mahn, A Meinhardt, M Zimmermann, ... haematologica 95 (2), 253, 2010 | 156 | 2010 |
Relapsed or refractory anaplastic large-cell lymphoma in children and adolescents after Berlin-Frankfurt-Muenster (BFM)–type first-line therapy: A BFM-group study W Woessmann, M Zimmermann, M Lenhard, B Burkhardt, C Rossig, ... Journal of Clinical Oncology 29 (22), 3065-3071, 2011 | 141 | 2011 |
ALK-positive anaplastic large cell lymphoma limited to the skin: clinical, histopathological and molecular analysis of 6 pediatric cases. A report from the ALCL99 study I Oschlies, J Lisfeld, L Lamant, A Nakazawa, ESG d'Amore, U Hansson, ... haematologica 98 (1), 50, 2013 | 139 | 2013 |
Non-Hodgkin's lymphoma in adolescents: experiences in 378 adolescent NHL patients treated according to pediatric NHL-BFM protocols B Burkhardt, I Oschlies, W Klapper, M Zimmermann, W Woessmann, ... Leukemia 25 (1), 153-160, 2011 | 134 | 2011 |
Prevalence, clinical pattern, and outcome of CNS involvement in childhood and adolescent non-Hodgkin's lymphoma differ by non-Hodgkin's lymphoma subtype: a Berlin-Frankfurt … J Salzburg, B Burkhardt, M Zimmermann, O Wachowski, W Woessmann, ... Journal of clinical oncology 25 (25), 3915-3922, 2007 | 126 | 2007 |
Phacomatosis pigmentokeratotica is caused by a postzygotic HRAS mutation in a multipotent progenitor cell L Groesser, E Herschberger, A Sagrera, T Shwayder, K Flux, L Ehmann, ... Journal of Investigative Dermatology 133 (8), 1998-2003, 2013 | 124 | 2013 |
Incidence and prognostic relevance of genetic variations in T-cell lymphoblastic lymphoma in childhood and adolescence BR Bonn, M Rohde, M Zimmermann, D Krieger, I Oschlies, F Niggli, ... Blood, The Journal of the American Society of Hematology 121 (16), 3153-3160, 2013 | 123 | 2013 |
Clinical, pathological and genetic features of primary mediastinal large B-cell lymphomas and mediastinal gray zone lymphomas in children I Oschlies, B Burkhardt, I Salaverria, A Rosenwald, ESG d’Amore, ... Haematologica 96 (2), 262, 2011 | 106 | 2011 |
Early assessment of minimal residual disease identifies patients at very high relapse risk in NPM-ALK–positive anaplastic large-cell lymphoma C Damm-Welk, L Mussolin, M Zimmermann, M Pillon, W Klapper, ... Blood, The Journal of the American Society of Hematology 123 (3), 334-337, 2014 | 99 | 2014 |
Gastrointestinal mesenchymal tumors–immunophenotypic classification and survival analysis P Rudolph, A Chiaravalli, U Pauser, I Oschlies, M Hillemanns, M Gobbo, ... Virchows Archiv 441, 238-248, 2002 | 98 | 2002 |